Brian R. Ott

Brian R. Ott

Auto-generated profile, based on publicly available information

Brian R. Ott

Department of Neurology Brown University Warren Alpert Medical School Providence Rhode Island USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
RRRebecca E Ready
Rebecca E Ready
BOBrian R Ott
Brian R Ott
Over the past 10 years, several instruments developed specifically for the assessment of Quality of Life (QOL) in dementia have been introduced. The goal of the current review is to present, compare, and critique existing QOL measures for dementia populations to assist investigators and clinicians in selecting the optimal inventory for their specific needs. Nine measures are reviewed with a focus on conceptualizations of QOL, psychometric data, targeted patient population, and administration and scoring procedures. Critical discussion and comparison of the instruments is presented after the scales are described individually. Differences in definitions of QOL, assessment procedures, and methods that were used to establish the validity of instruments are highlighted. An important direction for future research on QOL scales for dementia is to establish their responsiveness to change over time. It will also be important to identify factors that affect reports of QOL, determine the how perceived QOL affects decisions regarding the care of dementia patients, and evaluate interventions to increase patient QOL.

21 August 2018 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
BOBrian R. Ott
Brian R. Ott
RJRichard N. Jones
Richard N. Jones
LDLori A. Daiello
Lori A. Daiello
SMSuzanne M de la Monte
Suzanne M de la Monte
ESEdward G. Stopa
Edward G. Stopa
PGPaula Grammas
Paula Grammas
Background: The pathophysiology underlying altered blood-cerebrospinal fluid barrier (BCSFB) function in Alzheimer's disease (AD) is unknown but may relate to endothelial cell activation and cytokine mediated inflammation. Methods: Cerebrospinal fluid (CSF) and peripheral blood were concurrently collected from cognitively healthy controls (N = 21) and patients with mild cognitive impairment (MCI) (N = 8) or AD (N = 11). The paired serum and CSF samples were assayed for a panel of cytokines, chemokines, and related trophic factors using multiplex ELISAs. Dominance analysis models were conducted to determine the relative importance of the inflammatory factors in relationship to BCSFB permeability, as measured by CSF/serum ratios for urea, creatinine, and albumin. Results: BCSFB disruption to urea, a small molecule distributed by passive diffusion, had a full model coefficient of determination (r2) = 0.35, and large standardized dominance weights (>0.1) for monocyte chemoattractant protein-1, interleukin (IL)-15, IL-1rα, and IL-2 in serum. BCSFB disruption to creatinine, a larger molecule governed by active transport, had a full model r2 = 0.78, and large standardized dominance weights for monocyte inhibitor protein-1b in CSF and tumor necrosis factor-α in serum. BCSFB disruption to albumin, a much larger molecule, had a full model r2 = 0.62, and large standardized dominance weights for IL-17a, interferon-gamma, IL-2, and VEGF in CSF, as well IL-4 in serum. Conclusions: Inflammatory proteins have been widely documented in the AD brain. The results of the current study suggest that changes in BCSFB function resulting in altered permeability and transport are related to expression of specific inflammatory proteins, and that the shifting distribution of these proteins from serum to CSF in AD and MCI is correlated with more severe perturbations in BCSFB function.

4 May 2005 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
BOBrian R. Ott
Brian R. Ott
DADavid Anthony
David Anthony
GPGeorge D. Papandonatos
George D. Papandonatos
ADAnelyssa D'ABreu
Anelyssa D'ABreu
JBJeffrey Burock
Jeffrey Burock
JMJohn C. Morris
John C. Morris

1 September 2003 in Journal of Geriatric Psychiatry and Neurology
Verified
Journal Article
Closed access
PDF file
BOBrian R. Ott
Brian R. Ott
WHWilliam C. Heindel
William C. Heindel
WWWilliam M. Whelihan
William M. Whelihan
MCMark D. Caron
Mark D. Caron
APAndrea L. Piatt
Andrea L. Piatt
MDMargaret A. DiCarlo
Margaret A. DiCarlo
A battery of standard neuropsychological tests examining various features of executive function, attention, and visual perception was administered to 27 subjects with questionable to mild dementia and compared to a 4-point caregiver rating scale of driving ability. Based on the results of this study, a computerized maze task, employing 10 mazes, was administered to a second sample of 40 normal elders and questionable to moderately demented drivers. Comparison was made to the same caregiver rating scale as well as to crash frequency. In the first study of neuropsychological tests, errors on Porteus Mazes emerged as the only significant predictor of driving ability in a stepwise regression analysis. In the follow-up study employing the computerized mazes, all 10 mazes were significantly related to driving ability ratings. Computerized tests of maze performance offer promise as a screening tool to identify potential driving impairment among cognitively impaired elderly and demented drivers. (J Geriatr Psychiatry Neurol 2003; 16:151-155).

1 January 2017 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Closed access
CRCatherine Roe
Catherine Roe
PBPeggy P. Otd Barco
Peggy P. Otd Barco
DHDenise M. Head
Denise M. Head
NGNupur Ghoshal
Nupur Ghoshal
NSNatalie Ma Selsor
Natalie Ma Selsor
JMJohn C. Morris
John C. Morris
Postmortem brain studies of older drivers killed in car accidents indicate that many had Alzheimer disease (AD) neuropathologic changes. We examined whether AD biomarkers are related to driving performance among cognitively normal older adults. Individuals with normal cognition, aged 65+ years, and driving at least once per week, were recruited. Participants (N=129) took part in clinical assessments, a driving test, and positron emission tomography imaging with Pittsburgh compound B (PIB) and/or cerebrospinal fluid (CSF) collection. General linear models tested whether the number of driving errors differed as a function of each of the biomarker variables (mean cortical binding potential for PIB, and CSF Aβ42, tau, ptau181, tau/Aβ42, ptau181/Aβ42). Higher ratios of CSF tau/Aβ42, ptau181/Aβ42, and PIB mean cortical binding potential, were associated with more driving errors (P<0.05). Preclinical AD may have subtle cognitive and functional effects, which alone may go unnoticed. However, when combined, these changes may impact complex behaviors such as driving.

19 April 2000 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
PDF file
BOBrian R. Ott
Brian R. Ott
WHWilliam C. Heindel
William C. Heindel
WWWilliam M. Whelihan
William M. Whelihan
MCMark D. Caron
Mark D. Caron
APAndrea L. Piatt
Andrea L. Piatt
RNRichard B. Noto
Richard B. Noto
Single-photon emission computed tomography (SPECT) was used in this study to examine the neurophysiologic basis of driving impairment in 79 subjects with dementia. Driving impairment, as measured by caregiver ratings, was significantly related to regional reduction of right hemisphere cortical perfusion on SPECT, particularly in the temporo-occipital area. With increased severity of driving impairment, frontal cortical perfusion was also reduced. Clock drawing was more significantly related to driving impairment than the Mini-Mental State Examination (MMSE). Driving impairment in Alzheimer’s disease is related to changes in cortical function which vary according to the severity of the disease. Cognitive tests of visuoperceptual and executive functions may be more useful screening tools for identifying those at greatest risk for driving problems than examinations like the MMSE that are weighted toward left-hemisphere-based verbal tasks.